Difference between revisions of "MediaWiki:Sidebar"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) |
|||
| (8 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
* Index | * Index | ||
** mainpage|mainpage-description | ** mainpage|mainpage-description | ||
| − | ** | + | ** HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|Disclaimer |
| + | ** Editorial Board|Editorial board | ||
** Tutorial|Content tutorial | ** Tutorial|Content tutorial | ||
** How to contribute|Want to add info? | ** How to contribute|Want to add info? | ||
| − | * Top pages | + | * Top cancer pages |
| − | ** | + | ** Diffuse large B-cell lymphoma|1. DLBCL |
| − | ** | + | ** Breast cancer|2. Breast cancer |
| − | + | ** Non-small cell lung cancer |3. NSCLC | |
| − | ** Non-small cell lung cancer | | + | ** Colorectal cancer|4. Colorectal cancer |
| − | ** | + | ** Acute myeloid leukemia |5. AML |
| − | ** Acute myeloid leukemia | | + | ** Multiple myeloma|6. Multiple myeloma |
| − | ** | + | ** B-cell acute lymphoblastic leukemia |7. B-ALL |
| − | ** B-cell acute lymphoblastic leukemia | | + | ** Pancreatic cancer|8. Pancreatic cancer |
| − | ** | + | ** Bladder cancer|9. Bladder cancer |
| − | ** | + | ** Head_and_neck_cancer|10. H & N cancer |
| + | |||
* References | * References | ||
| + | ** Drug index|Drug index | ||
| + | ** Vesicant & irritant chemotherapy|Vesicants & irritants | ||
** ICD-9 codes|ICD billing codes | ** ICD-9 codes|ICD billing codes | ||
** Billing codes (CPT) and wRVUs|CPT E&M billing codes | ** Billing codes (CPT) and wRVUs|CPT E&M billing codes | ||
** Antiemesis|Antiemetic support | ** Antiemesis|Antiemetic support | ||
| − | |||
** Pathology|Pathology | ** Pathology|Pathology | ||
** Performance status|Performance status | ** Performance status|Performance status | ||
| Line 29: | Line 32: | ||
* Stay in touch | * Stay in touch | ||
** http://www.facebook.com/HemOnc.org|Like on Facebook | ** http://www.facebook.com/HemOnc.org|Like on Facebook | ||
| − | ** | + | ** https://www.linkedin.com/company/hemonc|LinkedIn |
** Mailing list for HemOnc.org |Mailing list | ** Mailing list for HemOnc.org |Mailing list | ||
* Contributors | * Contributors | ||
| − | |||
**Special:ContributionScores|Contribution scores | **Special:ContributionScores|Contribution scores | ||
** Help:Contents|Editing tutorial | ** Help:Contents|Editing tutorial | ||
** Style guide|Style guide | ** Style guide|Style guide | ||
| + | ** Eligibility criteria|Eligibility criteria | ||
** recentchanges-url|What's new | ** recentchanges-url|What's new | ||
* SEARCH | * SEARCH | ||
* TOOLBOX | * TOOLBOX | ||
Latest revision as of 18:38, 25 April 2024
- Index
- mainpage|mainpage-description
- HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|Disclaimer
- Editorial Board|Editorial board
- Tutorial|Content tutorial
- How to contribute|Want to add info?
- Top cancer pages
- Diffuse large B-cell lymphoma|1. DLBCL
- Breast cancer|2. Breast cancer
- Non-small cell lung cancer |3. NSCLC
- Colorectal cancer|4. Colorectal cancer
- Acute myeloid leukemia |5. AML
- Multiple myeloma|6. Multiple myeloma
- B-cell acute lymphoblastic leukemia |7. B-ALL
- Pancreatic cancer|8. Pancreatic cancer
- Bladder cancer|9. Bladder cancer
- Head_and_neck_cancer|10. H & N cancer
- References
- Drug index|Drug index
- Vesicant & irritant chemotherapy|Vesicants & irritants
- ICD-9 codes|ICD billing codes
- Billing codes (CPT) and wRVUs|CPT E&M billing codes
- Antiemesis|Antiemetic support
- Pathology|Pathology
- Performance status|Performance status
- Procedures|Procedures
- Steroid conversions|Steroid conversions
- Consult topics in hematology and oncology|Consults
- Hematology Oncology Fellowship Programs Directory|Fellowship programs
- External links|External links
- Stay in touch
- http://www.facebook.com/HemOnc.org%7CLike on Facebook
- https://www.linkedin.com/company/hemonc%7CLinkedIn
- Mailing list for HemOnc.org |Mailing list
- Contributors
- Special:ContributionScores|Contribution scores
- Help:Contents|Editing tutorial
- Style guide|Style guide
- Eligibility criteria|Eligibility criteria
- recentchanges-url|What's new
- SEARCH
- TOOLBOX